Daily Archives: September 2, 2022
2022 ACC Expert Consensus | Role of nonstatin therapies for LDL-cholesterol lowering and managing cardiovascular disease risk.
2 Sep, 2022 | 13:17h | UTCNews Release: ACC Issues Guidance to Address New Nonstatin Therapies – American College of Cardiology
Commentary: New on the Scene Nonstatin Drugs: Experts Provide Guidance – TCTMD
Commentary on Twitter
? ACC releases Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of ASCVD Risk
Read more: https://t.co/WDOSPgQ1bx #ACCClinicalDoc pic.twitter.com/nt8S2pdBgD
— American College of Cardiology (@ACCinTouch) August 25, 2022
RCT | Bedaquiline–Pretomanid–Linezolid regimens for drug-resistant tuberculosis.
2 Sep, 2022 | 13:16h | UTCBedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Three drug regimen with Linezolid 600 mg tied to better outcomes in drug-resistant TB – Medical Dialogues
RCT | Fractional flow reserve or intravascular ultrasonography to guide percutaneous coronary intervention.
2 Sep, 2022 | 13:15h | UTCFractional Flow Reserve or Intravascular Ultrasonography to Guide PCI – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Fractional Flow Reserve Noninferior to IVUS for Guiding PCI – HealthDay
Cohort Studies | Increased consumption of ultra-processed foods linked to increased risk of mortality and cancer.
2 Sep, 2022 | 13:15h | UTCEditorial: The trouble with ultra-processed foods – The BMJ
Commentaries:
Ultraprocessed foods linked to cancer and early death, studies find – CNN
New research gives more reasons to eat less-processed food – The Guardian
Systematic Review | Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse.
2 Sep, 2022 | 13:08h | UTC
Commentary on Twitter
❓ What is the effectiveness and safety of luteal support for those trying to conceive by intrauterine insemination #IUI or by sexual intercourse?
New @CochraneCGF systematic review looks at the evidence from 25 RCTs involving 5,111 participants. https://t.co/jjsetCMo3E pic.twitter.com/tWNtGx8rdC— The Cochrane Library (@CochraneLibrary) September 2, 2022
JCS 2022 Guideline on management and re-interventional therapy in patients with congenital heart disease in the long-term after the initial repair.
2 Sep, 2022 | 13:10h | UTC
M-A | Which surgeries are the best choice for chronic pancreatitis.
2 Sep, 2022 | 13:05h | UTC
Systematic Review | Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use.
2 Sep, 2022 | 13:07h | UTC
Systematic Review | Adverse drug reactions in pediatric onco-hematology
2 Sep, 2022 | 13:05h | UTCAdverse Drug Reactions in Pediatric Oncohematology: A Systematic Review – Frontiers in Pharmacology
Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management.
2 Sep, 2022 | 13:02h | UTC
3-year outcomes of a RCT | First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma.
2 Sep, 2022 | 13:04h | UTCOriginal Study: Randomized trial: First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma
Efficacy and activity of PD-1 blockade in patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis with focus on the value of PD-L1 combined positive score
2 Sep, 2022 | 13:03h | UTC